-
1
Rituximab-induced serum sickness: Not so uncommon
Published 2018-01-01Subjects: Get full text
Article -
2
Exploration of rituximab treatment strategies for membranous nephropathy adapted to the Chinese healthcare environment
Published 2025-01-01Subjects: Get full text
Article -
3
Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
Published 2019-03-01Subjects: Get full text
Article -
4
-
5
Microangiopathic Hemolytic Anemia: A Rare Complication of Acute Pancreatitis
Published 2025-01-01Subjects: Get full text
Article -
6
The changing landscape of treatment for acquired hemophilia A
Published 2025-01-01Subjects: Get full text
Article -
7
Guillain–barre syndrome as a presenting feature of systemic lupus erythematosus in a child and it's complete resolution with rituximab treatment
Published 2019-01-01Subjects: Get full text
Article -
8
Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis
Published 2018-01-01Subjects: Get full text
Article -
9
Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study
Published 2025-01-01Subjects: Get full text
Article -
10
RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC
Published 2024-02-01Subjects: Get full text
Article -
11
Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension
Published 2025-01-01Subjects: Get full text
Article -
12
A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
Published 2024-11-01Subjects: Get full text
Article -
13
Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality
Published 2025-01-01Subjects: “…rituximab…”
Get full text
Article -
14
Rituximab (monoclonal anti-CD20 antibody) induced posterior reversible encephalopathy syndrome (PRES): A case report and literature review
Published 2025-03-01Subjects: Get full text
Article -
15
-
16
Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
Published 2025-01-01Subjects: Get full text
Article -
17
-
18
The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
Published 2025-02-01Subjects: Get full text
Article -
19
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Published 2025-01-01Subjects: Get full text
Article -
20
Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis
Published 2025-01-01Subjects: “…Rituximab…”
Get full text
Article